E
Esben Clapp
Researcher at Copenhagen University Hospital
Publications - 1
Citations - 29
Esben Clapp is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Placebo-controlled study & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial.
Marie Warrer Munch,Tine Sylvest Meyhoff,Marie Helleberg,Maj Brit Nørregaard Kjær,Anders Granholm,Carl Johan Steensen Hjortsø,Thomas Steen Jensen,Morten Hylander Møller,Peter Buhl Hjortrup,Mik Wetterslev,Gitte Kingo Vesterlund,Lene Russell,Vibeke Lind Jørgensen,Klaus Tjelle Kristiansen,Thomas Benfield,Charlotte Suppli Ulrik,Anne Sofie Andreasen,Morten H. Bestle,Morten H. Bestle,Lone Musaeus Poulsen,Thomas Hildebrandt,Lene Surland Knudsen,Anders Pape Møller,Christoffer Sølling,Anne Craveiro Brøchner,Bodil Steen Rasmussen,Henrik Nielsen,Steffen Christensen,Thomas Strøm,Maria Cronhjort,Rebecka Rubenson Wahlin,Stephan M. Jakob,Luca Cioccari,Balasubramanian Venkatesh,Naomi E Hammond,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha,Sheila Nainan Myatra,Marie Qvist Jensen,Jens Wolfgang Leistner,Vibe Sommer Mikkelsen,Jens S. Svenningsen,Signe Bjørn Laursen,Emma Victoria Hatley,Camilla Meno Kristensen,Ali Al-Alak,Esben Clapp,Trine Bak Jonassen,Caroline Løkke Bjerregaard,Niels Christian Haubjerg Østerby,Mette Mindedahl Jespersen,Dalia Abou-Kassem,Mathilde Languille Lassen,Reem Zaabalawi,Mohammed Mahmoud Daoud,Suhayb Abdi,Nick Meier,Kirstine la Cour,Cecilie Bauer Derby,Birka Ravnholt Damlund,Jens Laigaard,Lene Lund Andersen,Johan Mikkelsen,Jeppe Lundholm Stadarfeld Jensen,Anders Hørby Rasmussen,Emil Arnerlöv,Mathilde Lykke,Mikkel Zacharias Bystrup Holst-Hansen,Boris Wied Tøstesen,Janne Schwab,Janne Schwab,Emilie Kabel Madsen,Christian Gluud,Christian Gluud,Theis Lange,Anders Perner +76 more
TL;DR: The COVID STEROID trial as discussed by the authors evaluated the effects of low-dose hydrocortisone on patient-centred outcomes in adults with COVID-19 and severe hypoxia.